Prospective cohort study investigates GNRI's role in predicting outcomes in older adults after hip fracture surgeries, suggesting its prognostic value.
The GNRI is an objective nutritional status screening tool. This study aimed to investigate the prognostic value of GNRI in predicting long-term outcomes of geriatric hip fracture patients. We prospectively enrolled patients aged ≥ 65 years who underwent hip fracture surgery between November 2018 and November 2019. Admission GNRI was categorized into quartiles (Q1 ≤ 96, Q2 96–101, Q3 101–104, Q4 > 104). Patients were followed up at 30 days, 120 days, 1 year and 3 years postoperatively. Cox proportional hazards model and ROC curve were performed to evaluate mortality risk; multiple logistic regression identified the value for recovery of pre-fracture mobility. Multiple linear regression and generalized estimating equations assessed associations between GNRI and EQ-5D utility scores. Of the 1092 patients, 947 were eligible for the research. The ROC of GNRI for predicting mortality was set. (AUC 0.726, 95% CI 0.687–0.766) Patients in Q2, Q3 and Q4 had significantly lower mortality risks (HRs 0.68, 95% CI 0.48–0.97; 0.47, 95% CI 0.31–0.72; and 0.23, 95% CI 0.13–0.42, respectively) comparing to Q1. Even after applying propensity score matching (PSM), individuals with higher GNRI still remained lower mortality risk. (HRs 0.56, 95% CI 0.34–0.91 and 0.55, 95% CI 0.36–0.85) Compared to Q1, patients in Q4 had a significantly increased possibility of achieving recovery at 1-year (OR 1.71, 95% CI 1.03–2.83, P = 0.037) and 3-year (OR 1.77, 95% CI 1.02–3.07, P = 0.042) follow-up. Admission GNRI was positively associated with EQ-5D utility scores at all follow-ups’ assessments (all P < 0.001), patients with higher GNRI exhibited better quality of life. The GNRI upon admission is potentially a reliable and independent prognostic indicator of long-term mortality, functional status and quality of life in Chinese geriatric hip fracture patients. This study was prospectively registered at ClinicalTrials.gov (Identifier: NCT03184896, Registration Date (First Posted): 2017-06-14) prior to the enrollment of participants.
No takes yet. Share an insight, caveat, or question.
Peng et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: